Glioblastoma

Filter by Popularity: - - - -
Searching for "Glioblastoma"
Thumbnail
Astellas Pharma slides further into regenerative medicine. Sorrento takes the first step in a CAR-T trial for glioblastoma. Galmed flops in a mid-stage HIV lipo... [Read More]
Researchers have produced a new and freely available computer program that predicts cancer cell motion and spread with high accuracy. This new system gives researchers... [Read More]
CULVER CITY, Calif. -- NantKwest Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage... [Read More]
Thumbnail
A cold virus that attacks tumor cells and triggers an immune response significantly extended the lives of a subset of patients with the deadliest form... [Read More]
Thumbnail
A cold virus that attacks tumor cells and triggers an immune response significantly extended the lives of a subset of patients with the deadliest form... [Read More]
A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live... [Read More]
Thumbnail
Meghan McCain appeared on CNN to talk about her father's, John McCain, progress after he was diagnosed with glioblastoma, an aggressive form of brain cancer, last... [Read More]
Thumbnail
Sen. McCain was diagnosed with primary glioblastoma, an aggressive form of brain cancer, last summer and has been undergoing chemotherapy si... [Read More]
The addition of tumour-treating fields to standard gioblastoma therapy improves progression-free survival (PFS) and does not negatively affect patients' health-related quality of life (HRQoL), according... [Read More]
Thumbnail
When Leland Dunwoodie, an undergraduate biochemistry student at Clemson University, approached his professor about wanting to start research on "some human stuff" in the spring... [Read More]
Thumbnail
The stock is certainly risky given the monumental late-stage clinical failure of the company's glioblastoma immunotherapy Rintega with no other candidates in th... [Read More]
Thumbnail
ELIANA makes Novartis' CAR-T cells the most advanced to date. The FDA approves Alnylam's application for review. NovoCure clearing all hurdles in glioblastoma. [Read More]
Thumbnail
A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer. [Read More]
Jump To: